378 related articles for article (PubMed ID: 23631257)
1. [Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
Kezuka T
Nippon Ganka Gakkai Zasshi; 2013 Mar; 117(3):270-91; discussion 292. PubMed ID: 23631257
[TBL] [Abstract][Full Text] [Related]
2. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.
Stiebel-Kalish H; Lotan I; Brody J; Chodick G; Bialer O; Marignier R; Bach M; Hellmann MA
PLoS One; 2017; 12(1):e0170847. PubMed ID: 28125740
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
4. Visual functional and histopathological correlation in experimental autoimmune optic neuritis.
Matsunaga Y; Kezuka T; An X; Fujita K; Matsuyama N; Matsuda R; Usui Y; Yamakawa N; Kuroda M; Goto H
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6964-71. PubMed ID: 22969072
[TBL] [Abstract][Full Text] [Related]
5. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
7. Roles of Treg/Th17 Cell Imbalance and Neuronal Damage in the Visual Dysfunction Observed in Experimental Autoimmune Optic Neuritis Chronologically.
Liu Y; You C; Zhang Z; Zhang J; Yan H
Neuromolecular Med; 2015 Dec; 17(4):391-403. PubMed ID: 26318182
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan.
Ishikawa H; Kezuka T; Shikishima K; Yamagami A; Hiraoka M; Chuman H; Nakamura M; Hoshi K; Goseki T; Mashimo K; Mimura O; Yoshitomi T; Tanaka K;
Ophthalmology; 2019 Oct; 126(10):1385-1398. PubMed ID: 31196727
[TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental autoimmune optic neuritis by the novel agent fingolimod.
An X; Kezuka T; Usui Y; Matsunaga Y; Matsuda R; Yamakawa N; Goto H
J Neuroophthalmol; 2013 Jun; 33(2):143-8. PubMed ID: 23609767
[TBL] [Abstract][Full Text] [Related]
10. [NMO spectrum disorders and anti AQP4 antibody].
Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
[TBL] [Abstract][Full Text] [Related]
12. Suppression of murine experimental autoimmune optic neuritis by mature dendritic cells transfected with calcitonin gene-related Peptide gene.
Matsuda R; Kezuka T; Nishiyama C; Usui Y; Matsunaga Y; Okunuki Y; Yamakawa N; Ogawa H; Okumura K; Goto H
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5475-85. PubMed ID: 22807299
[TBL] [Abstract][Full Text] [Related]
13. Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
Sun L; Weng H; Li Z
Int J Clin Exp Pathol; 2015; 8(12):15749-58. PubMed ID: 26884844
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 gene-transfected mature dendritic cells suppress murine experimental autoimmune optic neuritis.
Matsuda R; Kezuka T; Nishiyama C; Usui Y; Matsunaga Y; Okunuki Y; Yamakawa N; Ogawa H; Okumura K; Goto H
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7235-45. PubMed ID: 23033382
[TBL] [Abstract][Full Text] [Related]
15. Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
Jelcic I; Hanson JVM; Lukas S; Weber KP; Landau K; Pless M; Reindl M; Weller M; Martin R; Lutterotti A; Schippling S
J Neuroophthalmol; 2019 Mar; 39(1):3-7. PubMed ID: 30015656
[TBL] [Abstract][Full Text] [Related]
16. Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
Kezuka T; Usui Y; Yamakawa N; Matsunaga Y; Matsuda R; Masuda M; Utsumi H; Tanaka K; Goto H
J Neuroophthalmol; 2012 Jun; 32(2):107-10. PubMed ID: 22157536
[TBL] [Abstract][Full Text] [Related]
17. Protective Role of Limitrin in Experimental Autoimmune Optic Neuritis.
Chun BY; Kim JH; Jung YK; Choi YS; Kim G; Yonezawa T; Suk K
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):8. PubMed ID: 34232258
[TBL] [Abstract][Full Text] [Related]
18. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Das A; Guyton MK; Smith A; Wallace G; McDowell ML; Matzelle DD; Ray SK; Banik NL
J Neurochem; 2013 Jan; 124(1):133-46. PubMed ID: 23106593
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G
J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
[TBL] [Abstract][Full Text] [Related]
20. Preclinical stress originates in the rat optic nerve head during development of autoimmune optic neuritis.
Stojic A; Bojcevski J; Williams SK; Bas-Orth C; Nessler S; Linington C; Diem R; Fairless R
Glia; 2019 Mar; 67(3):512-524. PubMed ID: 30578556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
